Overview

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is an IRB-approved multicenter study.This non-inferiority study aims to evaluate differential healing rates between Lavior Diabetic Wound Gel and other Hydrogels. Study therapy will be started in the outpatient setting and followed accordingly.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Lavior Medical, Inc.